The DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*
Abstract
The epithelial ovarian carcinomas, which make up more than 85% of human ovarian cancer, arise in the ovarian surface epithelium (OSE). The etiology and early events in the progression of these carcinomas are among the least understood of all major human malignancies because there are no appropriate animal models, and because methods to culture OSE have become available only recently. The objective of this article is to review the cellular and molecular mechanisms that underlie the control of normal and neoplastic OSE cell growth, differentiation, and expression of indicators of neoplastic progression. We begin with a brief discussion of the development of OSE, from embryonic to the adult. The pathological and genetic changes of OSE during neoplastic progression are next summarized. The histological characteristics of OSE cells in culture are also described. Finally, the potential involvement of hormones, growth factors, and cytokines is discussed in terms of their contribution to our understanding of the physiology of normal OSE and ovarian cancer development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., & Waterfield, M. D. (1984) · Nature · doi:10.1038/307521a0 · Cited by 2,516
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Transforming growth factor beta
(2011) · SpringerReference · doi:10.1007/springerreference_39918 · Cited by 1,944
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer
Nicolaides, N. C., Papadopoulos, N., Liu, B., Weit, Y.-F., Carter, K. C., Ruben, S. M., Rosen, C. A., Haseltine, W. A., Fleischmann, R. D., Fraser, C. M., et al. (1994) · Nature · doi:10.1038/371075a0 · Cited by 1,545
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,526
Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.737 · Cited by 1,380
Development of Follicles in the Mammalian Ovary
Hirshfield, A. N. (1991) · International Review of Cytology · doi:10.1016/s0074-7696(08)61524-7 · Cited by 1,277
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., & Toyoshima, K. (1986) · Nature · doi:10.1038/319230a0 · Cited by 1,204
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,155
Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid
Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D., & Spiess, J. (1986) · Nature · doi:10.1038/321776a0 · Cited by 1,154
The Fgf Family of Growth Factors and Oncogenes
(1992) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60305-x · Cited by 1,145
INCESSANT OVULATION—A FACTOR IN OVARIAN NEOPLASIA ?
Fathalla, M. F. (1971) · The Lancet · doi:10.1016/s0140-6736(71)92335-x · Cited by 1,119
Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin
Ling, N., Ying, S.-Y., Ueno, N., Shimasaki, S., Esch, F., Hotta, M., & Guillemin, R. (1986) · Nature · doi:10.1038/321779a0 · Cited by 1,081
Whittmore, A. S., Harris, R., & Itnyre, J. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116427 · Cited by 1,000
The CA 125 tumour-associated antigen: a review of the literature
Jacobs, I., & Bast, R. C. (1989) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136832 · Cited by 955
Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., & Senger, D. R. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.2.211 · Cited by 898
Molecular alterations of the AKT 2 oncogene in ovarian and breast carcinomas
Bellacosa, A., De Feo, D., Godwin, A. K., Bell, D. W., Cheng, J. Q., Altomare, D. A., Wan, M., Dubeau, L., Scambia, G., Masciullo, V., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640412 · Cited by 837
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
Berchuck, A., Kamel, A., Whitaker, R. S., Kerns, B. J., Olt, G. J., Kinney, R., Soper, J. T., Dodge, R. K., Clarke‐Pearson, D. L., & Marks, P. J. (1990) · PubMed · Cited by 760
Obituary. Rupert Samuel Bruce Pearson.
Dm, O. (1974) · PubMed · Cited by 759
Kraus, M. H., Issing, W., Miki, T., Popescu, N. C., & Aaronson, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9193 · Cited by 737
Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 713
Hoschuetzky, H., Aberle, H., & Kemler, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1375 · Cited by 711
Sonnenberg, E., Meyer, D., Weidner, K. M., & Birchmeier, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.1.223 · Cited by 698
Transforming Growth Factor‐β: Major Role in Regulation of Extracellular Matrix
ROBERTS, A. B., HEINE, U. I., FLANDERS, K. C., & SPORN, M. B. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17931.x · Cited by 696
Vascular endothelial growth factor and its receptors
Klagsbrun, M., & A. D'Amore, P. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00027-5 · Cited by 682
López-Casillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S., & Massague, J. (1991) · Cell · doi:10.1016/0092-8674(91)90073-8 · Cited by 676
Twenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
Senger, D. R., Perruzzi, C. A., Feder, J., & Dvorak, H. F. (1986) · PubMed · Cited by 646
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., & Carraway, K. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36676-0 · Cited by 643
Expression cloning and characterization of the TGF-β type III receptor
Wang, X.-F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F., & Weinberg, R. A. (1991) · Cell · doi:10.1016/0092-8674(91)90074-9 · Cited by 637
Receptors for the TGF-β family
Massagué, J. (1992) · Cell · doi:10.1016/0092-8674(92)90627-o · Cited by 637
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Xu, Y. (1998) · JAMA · doi:10.1001/jama.280.8.719 · Cited by 637
Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Münger, K., Howley, P. M., & Moses, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90188-k · Cited by 609
Kabawat, S. E., Bast, R. C., Bhan, A. K., Welch, W. R., Knapp, R. C., & Colvin, R. B. (1983) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198303000-00005 · Cited by 588
Possible Role of Ovarian Epithelial Inflammation in Ovarian Cancer
Ness, R. B., & Cottreau, C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.17.1459 · Cited by 588
Sternberg, S. S., & Antonioli, D. A. (1994) · Raven Press eBooks · Cited by 568
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60784-8 · Cited by 540
Determinants of Ovarian Cancer Risk. II. Inferences Regarding Pathogenesis 2
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.4.717 · Cited by 535
Whittemore, A. S., Harris, R., Itnyre, J., Halpern, J., & the Collaborative Ovarian Cancer Group (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116426 · Cited by 525
BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells
Fan, S., Wang, J.-A., Yuan, R., Ma, Y., Meng, Q., Erdos, M. R., Pestell, R. G., Yuan, F., Auborn, K. J., Goldberg, I. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1354 · Cited by 491
Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H., Krajewski, S., Reed, J., Hoffman‐Liebermann, B., & Liebermann, D. A. (1994) · PubMed · Cited by 478
Expression of the Met/HGF receptor in normal and neoplastic human tissues.
Renzo, M. F. D., Narsimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Médico, E., Gaglia, P., Zara, P., & Comoglio, P. M. (1991) · PubMed · Cited by 474
Chemical and Biological Characterization of the Inhibin Family of Protein Hormones
VALE, W., RIVIER, C., HSUEH, A., CAMPEN, C., MEUNIER, H., BICSAK, T., VAUGHAN, J., CORRIGAN, A., BARDIN, W., SAWCHENKO, P., et al. (1988) · Proceedings of the 1987 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571144-9.50005-3 · Cited by 457
Expression of Vascular Endothelial Growt Factor and Its Receptors fit and KDR in Ovarian Carcinoma
Boocock, C. A., Charnock-Jones, D. S., Sharkey, A. M., McLaren, J., Barker, P. J., Wright, K. A., Twentyman, P. R., & Smith, S. K. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.7.506 · Cited by 456
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4
Plowman, G. D., Green, J. M., Culouscou, J.-M., Carlton, G. W., Rothwell, V. M., & Buckley, S. (1993) · Nature · doi:10.1038/366473a0 · Cited by 441
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
OBATA, K., Morland, S. J., Watson, R. H., Hitchcock, A., Chenevix‐Trench, G., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 429
Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B., & Sporn, M. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8772 · Cited by 418
Role of Vascular Endothelial Growth Factor in Ovarian Cancer
Mesiano, S., Ferrara, N., & Jaffe, R. B. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65669-6 · Cited by 392
Tolis, G., Ackman, D., Stellos, A., Mehta, A., Labrie, F., Fazekas, A. T., Comaru-Schally, A. M., & Schally, A. V. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.5.1658 · Cited by 368
Yamamoto, S., Konishi, I., Mandai, M., Kuroda, H., Komatsu, T., Nanbu, K., Sakahara, H., & Mori, T. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.537 · Cited by 356
Breast and ovarian cancer incidence after infertility and in vitro fertilisation
Venn, A., Watson, L., Lumley, J. M., Gilles, G., King, C., & Healy, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91687-3 · Cited by 329
Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.
Xu, Y., Gaudette, D. C., Boynton, J., Frankel, A., Fang, X. J., Sharma, A., Hurteau, J. A., Casey, G., Goodbody, A., & Mellors, A. (1995) · PubMed · Cited by 322
Insulin-like Growth Factors and Cancer
LeRoith, D., Baserga, R., Helman, L., & Roberts Jr., C. T. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-1-199501010-00009 · Cited by 317
Vimentin contributes to human mammary epithelial cell migration
Gilles, C., Polette, M., Zahm, J.-M., Tournier, J.-M., Volders, L., Foidart, J.-M., & Birembaut, P. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.24.4615 · Cited by 314
Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo.
Brady-Kalnay, S. M., Rimm, D. L., & Tonks, N. K. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.4.977 · Cited by 305
Brinkmann, V, Foroutan, H., Sachs, M., Weidner, K. M., & Birchmeier, W. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.6.1573 · Cited by 296
NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas
Yu, Y., Xu, F., Peng, H., Fang, X., Zhao, S., Li, Y., Cuevas, B., Kuo, W.-L., Gray, J. W., Siciliano, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.214 · Cited by 291
A Transforming Growth Factor β Type I Receptor that Signals to Activate Gene Expression
Bassing, C. H., Yingling, J. M., Howe, D. J., Wang, T., He, W. W., Gustafson, M. L., Shah, P., Donahoe, P. K., & Wang, X.-F. (1994) · Science · doi:10.1126/science.8272871 · Cited by 289
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204976 · Cited by 288
Human Vascular Permeability Factor
Connolly, D. T., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R., & Feder, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47212-8 · Cited by 284
Lau, K.-M., Mok, S. C., & Ho, S.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5722 · Cited by 277
Vascular Endothelial Growth Factor is Expressed in Rat Corpus Luteum
PHILLIPS, H. S., HAINS, J., LEUNG, D. W., & FERRARA, N. (1990) · Endocrinology · doi:10.1210/endo-127-2-965 · Cited by 277
Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction.
Rosen, E. M., Nigam, S. K., & Goldberg, I. D. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.1783 · Cited by 277
Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
Schally, A., & Nagy, A. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1410001 · Cited by 271
Pathology of ovarian cancer precursors
Scully, R. E. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590928 · Cited by 264
Salazar, H., Godwin, A. K., Daly, M. B., Laub, P. B., Hogan, W. M., Rosenblum, N., Boente, M. P., Lynch, H. T., & Hamilton, T. C. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.24.1810 · Cited by 264
Dubeau, L. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5275 · Cited by 262
Activin Receptors and Cellular Signaling by the Receptor Serine Kinase Family
MATHEWS, L. S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-310 · Cited by 260
Vascular permeability factor gene expression in normal and neoplastic human ovaries.
Olson, T. A., Mohanraj, D., Carson, L. F., & Ramakrishnan, S. (1994) · PubMed · Cited by 257
E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium
Auersperg, N., Pan, J., Grove, B. D., Peterson, T., Fisher, J., Maines-Bandiera, S., Somasiri, A., & Roskelley, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6249 · Cited by 254
Self-citation5462925 Transforming growth factor beta2,3
(1996) · Biotechnology Advances · doi:10.1016/s0734-9750(97)81916-7 · Cited by 252
FANG, X., GAUDETTE, D., FURUI, T., MAO, M., ESTRELLA, V., EDER, A., PUSTILNIK, T., SASAGAWA, T., LAPUSHIN, R., YU, S., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06550.x · Cited by 248
Czernobilsky, B., Moll, R., Levy, R., & Franke, W. W. (1985) · PubMed · Cited by 244
Goldman, R., Ben Levy, R., Peles, E., & Yarden, Y. (1990) · Biochemistry · doi:10.1021/bi00502a002 · Cited by 244
Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer
Berek, J. S., Chung, C., Kaldi, K., Watson, J. M., Knox, R. M., & Martínez-Maza, O. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90582-c · Cited by 238
Fynan, T., & Reiss, M. (1993) · PubMed · Cited by 236
Peles, E., Ben-Levy, R., Tzahar, E., Liu, N., Wen, D., & Yarden, Y. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05737.x · Cited by 233
Fredrickson, T. N. (1987) · Environmental Health Perspectives · doi:10.1289/ehp.877335 · Cited by 232
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer
Berchuck, A., Rodriguez, G. C., Kamel, A., Dodge, R. K., Soper, J. T., Clarke-Pearson, D. L., & Bast, R. C. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)80044-x · Cited by 231
E-cadherin Regulates Anchorage-independent Growth and Survival in Oral Squamous Cell Carcinoma Cells
Kantak, S. S., & Kramer, R. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16953 · Cited by 227
Daughaday, W. H. (1990) · Endocrinology · doi:10.1210/endo-127-1-1 · Cited by 226
Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors
Healy, D. L., Burger, H. G., Mamers, P., Jobling, T., Bangah, M., Quinn, M., Grant, P., Day, A. J., Rome, R., & Campbell, J. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292104 · Cited by 221
Watson, J. M., Sensintaffar, J., Berek, J. S., & Martı́nez-Maza, O. (1990) · PubMed · Cited by 221
Human menopausal gonadotropin and the risk of epithelial ovarian cancer
Shushan, A., Paltiel, O., Iscovich, J., Elchalal, U., Peretz, T., & Schenker, J. G. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58020-0 · Cited by 220
Henriksen, R., Funa, K., Wilander, E., Bäckström, T., Ridderheim, M., & Öberg, K. (1993) · PubMed · Cited by 219
Cárcamo, J., Zentella, A., & Massagué, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1573 · Cited by 216
McCawley, L. J., O'Brien, P., & Hudson, L. G. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199808)176:2<255::aid-jcp4>3.0.co;2-n · Cited by 215
Loss of receptors for transforming growth factor beta in human T-cell malignancies.
Kadin, M. E., Cavaille-Coll, M. W., Gertz, R., Massagué, J., Cheifetz, S., & George, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6002 · Cited by 213
Endocrine Factors in Common Epithelial Ovarian Cancer*
RAO, B. R., & SLOTMAN, B. J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-14 · Cited by 213
Overexpression of theMET/HGF receptor in ovarian cancer
Di Renzo, M. F., Olivero, M., Katsaros, D., Crepaldi, T., Gaglia, P., Zola, P., Sismondi, P., & Comoglio, P. M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580507 · Cited by 212
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
Bartlett, J., Langdon, S., Simpson, B., Stewart, M., Katsaros, D., Sismondi, P., Love, S., Scott, W., Williams, A., Lessells, A., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.53 · Cited by 211
A simplified method to culture human ovarian surface epithelium.
Kruk, P. A., Maines‐Bandiera, S., & Auersperg, N. (1990) · PubMed · Cited by 210
Self-citationDevelopmental and endocrine aspects of normal ovarian aging
te Velde, E. R., Scheffer, G. J., Dorland, M., Broekmans, F. J., & Fauser, B. C. J. M. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00171-3 · Cited by 210
Brandenberger, A. W., Tee, M. K., & Jaffe, R. B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4788 · Cited by 210
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60740-x · Cited by 208
Wu, S. M., Boyer, C. M., Whitaker, R. S., Berchuck, A., Wiener, J. R., Weinberg, J. B., & Bast, R. C. (1993) · PubMed · Cited by 208
Growth Factors Modulate Gonadotropin Receptor Induction in Granulosa Cell Cultures
Mondschein, J. S., & Schomberg, D. W. (1981) · Science · doi:10.1126/science.6258228 · Cited by 207
Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
Jiang, X., Morland, S. J., Hitchcock, A., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 207
Emons, G. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1458 · Cited by 204
Abu‐Jawdeh, G. M., Faix, J. D., Niloff, J. M., Tognazzi, K., Manseau, E. J., Dvorak, H. F., & Brown, L. (1996) · PubMed · Cited by 202
Tsao, S.-W., Mok, S. C., Fey, E. G., Fletcher, J. A., Wan, T. S. K., Chew, E.-C., Muto, M. G., Knapp, R. C., & Berkowitz, R. S. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1184 · Cited by 201
Emons, G., Ortmann, O., Becker, M., et al. (1993) · PubMed · Cited by 195
Yeo, K. T., Wang, H. H., Nagy, J. A., Sioussat, T. M., Ledbetter, S. R., Hoogewerf, A. J., Zhou, Y., Masse, E., Senger, D. R., & Dvorak, H. F. (1993) · PubMed · Cited by 194
Enomoto, T., Weghorst, C. M., Inoue, M., Tanizawa, O., & Rice, J. M. (1991) · PubMed Central · Cited by 192
Vascular endothelial growth factor and its receptors
Neufeld, G., Tessler, S., Gitay-Goren, H., Cohen, T., & Levi, B.-Z. (1994) · Progress in Growth Factor Research · doi:10.1016/0955-2235(94)90019-1 · Cited by 190
Auersperg, N., Maines‐Bandiera, S., Dyck, H. G., & Kruk, P. A. (1994) · PubMed · Cited by 189
Self-citationZheng, W. L., Magid, M. S., Kramer, E. E., & Chen, Y. T. (1996) · Europe PMC (PubMed Central) · Cited by 188
Inagaki, M., Moustakas, A., Lin, H. Y., Lodish, H. F., & Carr, B. I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5359 · Cited by 188
The p53 tumor suppressor gene frequently is altered in gynecologic cancers
Berchuck, A., Kohler, M. F., Marks, J. R., Wiseman, R., Boyd, J., & Bast, R. C. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70414-7 · Cited by 184
Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer
Kohler, M. F., Marks, J. R., Wiseman, R. W., Jacobs, I. J., Davidoff, A. M., Clarke-Pearson, D. L., Soper, J. T., Bast, R. C., & Berchuck, A. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1513 · Cited by 184
INHIBITION OF OVARIAN AND TESTICULAR STEROIODOGENESIS BY EPIDERMAL GROWTH FACTOR
Hsueh, A. J. W., Welsh, T. H., & Jones, P. B. C. (1981) · Endocrinology · doi:10.1210/endo-108-5-2002 · Cited by 183
Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis
Garg, P. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00139-2 · Cited by 182
Godwin, A. K., Testa, J. R., Handel, L. M., Liu, Z., Vanderveer, L. A., Tracey, P. A., & Hamilton, T. C. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.8.592 · Cited by 181
E-cadherin expression in human epithelial ovarian cancer and normal ovary
Sundfeldt, K., Piontkewitz, Y., Ivarsson, K., Nilsson, O., Hellberg, P., Brännströ:m, M., Janson, P.-O., Enerbäck, S., & Hedin, L. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970620)74:3<275::aid-ijc7>3.0.co;2-w · Cited by 180
Trelstad, R. L., Hayashi, A., Hayashi, K., & Donahoe, P. K. (1982) · Developmental Biology · doi:10.1016/0012-1606(82)90147-6 · Cited by 180
Malignant effusions contain lysophosphatidic acid (LPA)-like activity
Westermann, A. M., Havik, E., Postma, F. R., Beijnen, J. H., Dalesio, O., Moolenaar, W. H., & Rodenhuis, S. (1998) · Annals of Oncology · doi:10.1023/a:1008217129273 · Cited by 177
Localization of hepatocyte growth factor in human and rat tissues: An immunohistochemical study
Wolf, H. K., Zarnegar, R., & Michalopoulos, G. K. (1991) · Hepatology · doi:10.1002/hep.1840140314 · Cited by 173
The role of anti-Müllerian hormone in gonadal development
Josso, N., Racine, C., di Clemente, N., Rey, R., & Xavier, F. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00186-5 · Cited by 171
Boccaccio, C., Gaudino, G., Gambarotta, G., Galimi, F., & Comoglio, P. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99953-9 · Cited by 160
Aguilar, Z., Akita, R. W., Finn, R. S., Ramos, B. L., Pegram, M. D., Kabbinavar, F. F., Pietras, R. J., Pisacane, P. I., Sliwkowski, M. X., & Slamon, D. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202993 · Cited by 155
Kalkhoven, E., Roelen, B. A. J., de Winter, J. P., Mummery, C. L., Raaij, A. J. M. V. D. E.-V., van der Saag, P. T., & van der Burg, B. (1995) · PubMed · Cited by 155
Maines‐Bandiera, S., Kruk, P. A., & Auersperg, N. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91579-8 · Cited by 151
Self-citationQayum, A., Gullick, W. J., Clayton, R., Sikora, K., & Waxman, J. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.236 · Cited by 150
Cadherin Cell Adhesion Molecules in Differentiation and Embryogenesis
Marrs, J. A., & Nelson, W. J. (1996) · International review of cytology · doi:10.1016/s0074-7696(08)62222-6 · Cited by 146
Kacinski, B. M., Carter, D., Mittal, K., Yee, L. D., Scata, K. A., DONOFRIO, L. M., Chambers, S. K., Wang, K. I., Yang‐Feng, T. L., & Rohrschneider, L. R. (1990) · Europe PMC (PubMed Central) · Cited by 145
Robertson, S. A. (1996) · Biology of Reproduction · doi:10.1095/biolreprod54.1.183 · Cited by 144
p53 Mutations and Expression in Ovarian Cancers: Correlation with Overall Survival
Wen, W., Reles, A., Runnebaum, I. B., Sullivan‐Halley, J., Bernstein, L., Jones, L. A., Felix, J. C., Kreienberg, R., El‐Naggar, A. K., & Press, M. F. (1999) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199901000-00005 · Cited by 143
Ye, D., Mendelsohn, J. M., & Fan, Z. (1999) · Oncogene · doi:10.1038/sj.onc.1202319 · Cited by 142
Knecht, M., & Catt, K. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32787-x · Cited by 141
Kramer, B. S., Gohagan, J. K., Prorok, P. C., & Smart, C. R. (2010) · Cancer · doi:10.1002/cncr.2820710215 · Cited by 139
Effects of LHRH-analogues on mitogenic signal transduction in cancer cells
Emons, G., Müller, V., Ortmann, O., & Schulz, K. D. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00189-1 · Cited by 139
Regulation of Cellular and System Function by Activin
Woodruff, T. K. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00477-2 · Cited by 138
Association of ovarian Malignancy With Expression of Paltelet-Derived Endothelial Cell Growth Factor
Reynolds, K., Farzaneh, F., Collins, W. P., Campbell, S. C., Bourne, T., Lawton, F. E., Moghaddam, A., Harris, A. L., & Bicknell, R. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.16.1234 · Cited by 137
Zheng, W., Lu, J., Luo, F., Zheng, Y., Feng, Y.-J., Felix, J. C., Lauchlan, S. C., & Pike, M. C. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5628 · Cited by 136
Hartenbach, E. M., Olson, T. A., Goswitz, J. J., Mohanraj, D., Twiggs, L. B., Carson, L. F., & Ramakrishnan, S. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00350-9 · Cited by 133
Limonta, P., Moretti, R. M., Marelli, M. M., Dondi, D., Parenti, M. D., & Motta, M. (1999) · Endocrinology · doi:10.1210/endo.140.11.7087 · Cited by 127
Matsuura, K., Ohtake, H., Katabuchi, H., & Okamura, H. (1999) · Gynecologic and Obstetric Investigation · doi:10.1159/000052855 · Cited by 125
Therapeutic application of anti-growth factor receptor antibodies
Fan, Z., & Mendelsohn, J. M. (1998) · Current Opinion in Oncology · doi:10.1097/00001622-199801000-00011 · Cited by 119
Kang, S. K., Choi, K., Cheng, K. W., Nathwani, P. S., Auersperg, N., & Leung, P. C. K. (2000) · Endocrinology · doi:10.1210/endo.141.1.7250 · Cited by 118
Self-citationParrott, J. A., Vigne, J. L., Chu, B. Z., & Skinner, M. K. (1994) · Endocrinology · doi:10.1210/endo.135.2.8033804 · Cited by 117
Contralateral Ovary in Unilateral Ovarian Carcinoma
Mittal, K., Zeleniuch‐Jacquotte, A., Cooper, J. L., & Demopoulos, R. I. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199301000-00008 · Cited by 116
Flyvbjerg, A., Mogensen, O. E., Mogensen, B., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4085 · Cited by 114
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer
Rodriguez, G. C., Berchuck, A., Whitaker, R. S., et al. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90508-o · Cited by 114
Werness, B. A., Afify, A. M., Bielat, K. L., Eltabbakh, G. H., Piver, M. S., & Paterson, J. M. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90269-1 · Cited by 113
Berchuck, A., Rodriguez, G., Olt, G. J., et al. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91697-9 · Cited by 111
Testa, J. R., Getts, L. A., Salazar, H., Liu, Z., Handel, L. M., Godwin, A. K., & Hamilton, T. C. (1994) · PubMed · Cited by 110
Simone, N. D., Crowley, W. F., Wang, Q. F., Sluss, P. M., & Schneyer, A. L. (1996) · Endocrinology · doi:10.1210/endo.137.2.8593793 · Cited by 110
Loss of ovarian function promotes angiogenesis in human ovarian carcinoma
Schiffenbauer, Y. S., Abramovitch, R., Meir, G., Nevo, N., Holzinger, M., Itin, A., Keshet, E., & Neeman, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13203 · Cited by 109
Markham, P. D., Salahuddin, S. Z., Kalyanaraman, V. S., Popovič, M., Sarin, P. S., & Gallo, R. C. (1983) · International Journal of Cancer · doi:10.1002/ijc.2910310404 · Cited by 109
Kruk, P. A., Uitto, V., Firth, J. D., et al. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1320 · Cited by 109
Growth-Inhibitory Actions of Analogues of Luteinizing Hormone Releasing Hormone on Tumor Cells
Emons, G., Ortmann, O., Schulz, K.-D., et al. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00155-0 · Cited by 106
APC EXPRESSION IN NORMAL HUMAN TISSUES
Midgley, C., WHITE, S., Howitt, R., Save, V., Dunlop, M. G., Hall, P. A., Lane, D. P., Wyllie, A. H., & Bubb, V. J. (1997) · The Journal of Pathology · Cited by 102
Langdon, S. P., Hirst, G. L., Miller, E. P., Hawkins, R. A., Tesdale, A., Smyth, J. F., & Miller, W. R. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90019-1 · Cited by 101
Human ovarian surface epithelium in primary culture
Auersperg, N., Siemens, C. H., & Myrdal, S. E. (1984) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02618290 · Cited by 99
Self-citationTang, R., Ojeda‐Uribe, M., Pouillart, P., Scholl, S., Beuvon, F., & Mosseri, V. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240500403 · Cited by 98
WU, S. M., Rodabaugh, K. J., Martı́nez-Maza, O., Watson, J. M., Silberstein, D. S., Boyer, C. M., Peters, W. P., Weinberg, J. B., Berek, J. S., & Bast, R. C. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91379-o · Cited by 97
Deshane, J. S., Loechel, F., Conry, R. M., Gp, S., Cr, K., & Curiel, D. (1994) · PubMed · Cited by 97
Programmed Cell Death in Preovulatory Ovine Follicles
Murdoch, W. J. (1995) · Biology of Reproduction · doi:10.1095/biolreprod53.1.8 · Cited by 96
Wong, A. S. T., Maines‐Bandiera, S., Rosen, B. P., Wheelock, M. J., Johnson, K. R., Leung, P. C. K., Roskelley, C. D., & Auersperg, N. (1999) · International Journal of Cancer · Cited by 96
Self-citationExpression of cadherins and integrins in human endometrium throughout the menstrual cycle
van der Linden, P. J. Q., de Goeij, A. F. P. M., Dunselman, G. A. J., Erkens, H. W. H., & Evers, J. L. H. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57599-2 · Cited by 95
Karasik, A., Menczer, J., Pariente, C., et al. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.7508947 · Cited by 95
Inhibition of stromal matrix metalloproteases: Effects on breast-tumor promotion by fibroblasts
Noël, A., Hajitou, A., L'Hoir, C., Maquoi, E., Baramova, E. N., Lewalle, J.-M., Remacle, A. G., Kebers, F., Brown, P. D. N., Calberg‐Bacq, C. M., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980413)76:2<240::aid-ijc12>3.0.co;2-g · Cited by 94
Conover, C. A., Hartmann, L. C., Bradley, S. V., Stalboerger, P. G., Klee, G. G., Kalli, K. R., & Jenkins, R. B. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3861 · Cited by 93
Interleukin‐6 serum levels in patients with gynecological tumors
Scambia, G., Testa, U., Panici, P. B., Martucci, R., Foti, E., Petrini, M., Amoroso, M., Masciullo, V., Peschle, C., & Mancuso, S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570305 · Cited by 93
STILBŒSTROL (DIETHYLSTILBESTROL) AND THE RISK OF OVARIAN CANCER
Hoover, R. N., Gray, L., & Fraumeni, J. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90667-5 · Cited by 91
Stratton, J. F., BUCKLEY, C. H., Lowe, D., & Ponder, B. A. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.626 · Cited by 91
Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou, A. I., Jindal, S., Brown, T. J., & Letarte, M. (2000) · PubMed · Cited by 90
Serial propagation of human ovarian surface epithelium in tissue culture
Siemens, C. H., & Auersperg, N. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041340305 · Cited by 89
Self-citationCoupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors
Imai, A., Takagi, H., Horibe, S., Fuseya, T., & Tamaya, T. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784077 · Cited by 88
The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma.
Stack, M. S., Ellerbroek, S. M., & Fishman, D. A. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.3.569 · Cited by 87
Steroid hormone effects on the proliferation of human ovarian surface epithelium in vitro
Karlan, B. Y., Jones, J., Greenwald, M., et al. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90176-0 · Cited by 87
Ziltener, H. J., Maines‐Bandiera, S., Schrader, J. W., & Auersperg, N. (1993) · Biology of Reproduction · doi:10.1095/biolreprod49.3.635 · Cited by 87
Self-citationReview: Gonadotropins and Development of Ovarian Cancer
Konishi, I., Kuroda, H., & Mandai, M. (1999) · Oncology · doi:10.1159/000055274 · Cited by 86
Henriksen, R., Gobl, A., Wilander, E., et al. (1995) · PubMed · Cited by 84
Cell growth regulation in epithelial ovarian cancer
Bast, R. C., Boyer, C. M., Jacobs, I. J., et al. (1993) · Cancer · doi:10.1002/cncr.2820710426 · Cited by 83
Corps, A. N., Sowter, H., & Smith, S. K. (1997) · International Journal of Cancer · Cited by 83
Kacinski, B. M., Carter, D., Mittal, K., Kohorn, E. I., Bloodgood, R., Donahue, J. K., DONOFRIO, L. M., Edwards, R., Schwartz, P. E., Chambers, J. T., et al. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90113-7 · Cited by 83
Galtier, F., Capony, F., Maudelondé, T., & Rochefort, H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.6.1497 · Cited by 82
Increased E-Cadherin Expression in Ovarian Surface Epithelium
Maines‐Bandiera, S., & Auersperg, N. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199707000-00010 · Cited by 82
Self-citationThe RB family of cell cycle regulatory factors
Stiegler, P., Kasten, M. M., & Giordano, A. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<30::aid-jcb5>3.0.co;2-j · Cited by 82
The role of peptide growth factors in epithelial ovarian cancer.
Berchuck, A., Olt, G. J., Everitt, L., et al. (1990) · PubMed · Cited by 80
Presence of Activin, Inhibin, and Follistatin in Epithelial Ovarian Carcinoma
Welt, C. K., Lambert-Messerlian, G. M., Zheng, W., Crowley, W. F., & Schneyer, A. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4345 · Cited by 79
Zhang, S., Zhang, H. S., Cordón-Cardó, C., et al. (1998) · PubMed · Cited by 79
Gayther, S. A., Harrington, P. A., Russell, P. A., Kharkevich, G., Гарькавцева, Р. Ф., & Ponder, B. A. J. (1996) · PubMed Central · Cited by 78
Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury.
Dávila, R. M., & Crouch, E. C. (1993) · PubMed · Cited by 78
Estrogen action in human ovarian cancer
Clinton, G. M., & Hua, W. (1997) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(96)00216-8 · Cited by 78
Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: Where are we today?
Wallach, E. E., & Shoham, Z. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56928-3 · Cited by 78
Trolice, M. P., Pappalardo, A., & Peluso, J. J. (1997) · Endocrinology · doi:10.1210/endo.138.1.4836 · Cited by 75
Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary
Liu, Y., Lin, L., & Zarnegar, R. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90120-1 · Cited by 73
ERÄMAA, M., Hildén, K., Tuuri, T., & Ritvos, O. (1995) · Endocrinology · doi:10.1210/endo.136.10.7664658 · Cited by 73
van Dam, P. A., Vergote, I. B., Lowe, D. G., Watson, J. V., Damme, P. V., van der Auwera, J.-C., & Shepherd, J. H. (1994) · Journal of Clinical Pathology · doi:10.1136/jcp.47.10.914 · Cited by 73
Inhibin forms in serum from postmenopausal women with ovarian cancers
Robertson, D. M., Cahir, N. F., Burger, H., et al. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00656.x · Cited by 71
c‐myc over‐expression in human primary ovarian tumours: Its relevance to tumour progression
Tashiro, H., Miyazaki, K., Okamura, H., Iwai, A., & Fukumoto, M. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500528 · Cited by 71
Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer
Hung, M., Zhang, X., Yan, D., Zhang, H.-Z., He, G.-P., Zhang, T.-Q., & Shi, D.-R. (1992) · Cancer Letters · doi:10.1016/0304-3835(92)90166-s · Cited by 71
Cited by
Bapat, S. A., Mali, A. M., Koppikar, C. B., & Kurrey, N. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3931 · Cited by 760
Ovulation: Parallels With Inflammatory Processes
Duffy, D. M., Ko, C., Jo, M., Brannstrom, M., & Curry, T. E. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00075 · Cited by 513
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462
Multicellular spheroids in ovarian cancer metastases: Biology and pathology
Shield, K., Ackland, M. L., Ahmed, N., & Rice, G. E. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.11.032 · Cited by 412
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Levanon, K., Crum, C., & Drapkin, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1107 · Cited by 412
Metadata
- Authors
- Auersperg, N., Wong, A. S. T., Choi, K.-C., Kang, S. K., & Leung, P. C. K.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-04-01
- Volume
- 22
- Issue
- 2
- Pages
- 255-288
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2138202356
- Cited by
- 1,046
- References
- 272
- FWCI
- 34.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.